440 filings
Page 12 of 22
424B4
xoonxen9p4tbb f6vyq
26 Apr 19
Prospectus supplement with pricing info
3:56pm
CORRESP
0nu3hx6 sz
22 Apr 19
Correspondence with SEC
12:00am
8-K
yqqi9gmk7b5cxyoxriew
4 Apr 19
Termination of a Material Definitive Agreement
8:53pm
D
qb33x
27 Mar 19
$1.25M in equity / debt, sold $1.25M, 1 investor
3:43pm
8-K
4i4n3r1z e1z6
19 Mar 19
Entry into a Material Definitive Agreement
4:56pm
8-K
eybjvuhhe 2ke
4 Mar 19
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:16pm
EFFECT
g6oge1
20 Feb 19
Notice of effectiveness
12:15am
EFFECT
7o4829rl1f5t8bkgvxc5
15 Feb 19
Notice of effectiveness
12:15am
CORRESP
h0mtae ixglymv
13 Feb 19
Correspondence with SEC
12:00am
UPLOAD
1h9st5 s78uxf4lk0z37
11 Feb 19
Letter from SEC
12:00am
UPLOAD
11ho9
11 Feb 19
Letter from SEC
12:00am
8-K
dr18oio3m4c3
15 Jan 19
ContraVir Pharmaceuticals Announces Adjournment of Annual Meeting of Stockholders
8:38pm
8-K
lqcqyvayv
2 Jan 19
Regulation FD Disclosure
4:26pm